Literature DB >> 22359309

Multifactorial etiology of gastric cancer.

Jovanny Zabaleta1.   

Abstract

The prevalence of gastric cancer is associated with several factors including geographical location, diet, and genetic background of the host. However, it is evident that infection with Helicobacter pylori (H. pylori) is crucial for the development of the disease. Virulence of the bacteria is also important in modulating the risk of the disease. After infection, H. pylori gains access to the gastric mucosa and triggers the production of cytokines that promote recruitment of inflammatory cells, probably involved in tissue damage. Once the infection is established, a cascade of inflammatory steps associated with changes in the gastric epithelia that may lead to cancer is triggered. H. pylori-induced gastritis and H. pylori-associated gastric cancer have been the focus of extensive research aiming to discover the underlying mechanisms of gastric tissue damage. This research has led to the association of host genetic components with the risk of the disease. Among these is the presence of single nucleotide polymorphisms (SNPs) in several genes, including cytokine genes, which are able to differentially modulate the production of inflammatory cytokines and then modulate the risk of gastric cancer. Interestingly, the frequency of some of these SNPs is different among populations and may serve as a predictive factor for gastric cancer risk within that specific population. However, the role played by other genetic modifications should not be minimized. Methylation of gene promoters has been recognized as a major mechanism of gene expression regulation without changing the primary structure of the DNA. Most DNA methylation occurs in cytosine residues in CpG dinucleotide, but it can also be found in other DNA bases. DNA methyltransferases add methyl groups to the CpG dinucleotide, and when this methylation level is too high, the gene expression is turned off. In H. pylori infection as well as in gastric cancer, hypermethylation of promoters of genes involved in cell cycle control, metabolism of essential nutrients, and production of inflammatory mediators, among others, has been described. Interestingly, DNA changes like SNPs or mutations can create CpG sites in sequences where transcription factors normally sit, affecting transcription.In this chapter, we review the literature about the role of SNPs and methylation on H. pylori infection and gastric cancer, with big emphasis to the H. pylori role in the development of the disease due to the strong association between both.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359309      PMCID: PMC3625139          DOI: 10.1007/978-1-61779-612-8_26

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  213 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis.

Authors:  N A Tountas; V Casini-Raggi; H Yang; F S Di Giovine; M Vecchi; L Kam; L Melani; T T Pizarro; J I Rotter; F Cominelli
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

Review 3.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

4.  Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter.

Authors:  F Watt; P L Molloy
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

5.  Effects of Helicobacter pylori on proliferation of gastric epithelial cells in vitro.

Authors:  D T Smoot; Z Wynn; T B Elliott; C R Allen; G Mekasha; T Naab; H Ashktorab
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

6.  Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis.

Authors:  T Rokkas; S Ladas; C Liatsos; E Petridou; G Papatheodorou; S Theocharis; A Karameris; S Raptis
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

7.  Helicobacter pylori urease activity is toxic to human gastric epithelial cells.

Authors:  D T Smoot; H L Mobley; G R Chippendale; J F Lewison; J H Resau
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

8.  Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.

Authors:  R A Alm; L S Ling; D T Moir; B L King; E D Brown; P C Doig; D R Smith; B Noonan; B C Guild; B L deJonge; G Carmel; P J Tummino; A Caruso; M Uria-Nickelsen; D M Mills; C Ives; R Gibson; D Merberg; S D Mills; Q Jiang; D E Taylor; G F Vovis; T J Trust
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

9.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

10.  Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity.

Authors:  I Szabò; S Brutsche; F Tombola; M Moschioni; B Satin; J L Telford; R Rappuoli; C Montecucco; E Papini; M Zoratti
Journal:  EMBO J       Date:  1999-10-15       Impact factor: 11.598

View more
  49 in total

1.  SIRT1 counteracted the activation of STAT3 and NF-κB to repress the gastric cancer growth.

Authors:  Juanjuan Lu; Liping Zhang; Xiang Chen; Qiming Lu; Yuxia Yang; Jingping Liu; Xin Ma
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.

Authors:  Ming-Hui Xue; Guang-Yan Li; Xin-Jun Wu; Chao-Xian Zhang; Cai-Feng Zhang; Kong-Xi Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 3.  Association of XRCC3 gene rs861539 polymorphism with gastric cancer risk: evidence from a case-control study and a meta-analysis.

Authors:  Shidan Cheng; Liying Wang; Lei Wang; Zhengting Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

5.  CD133 Expression as a Helicobacter pylori-independent Biomarker of Gastric Cancer Progression.

Authors:  Rachel Howard; Sameer Al Diffalha; Jose Pimiento; Jaime Mejia; Heiko Enderling; Anna Giuliano; Domenico Coppola
Journal:  Anticancer Res       Date:  2018-08       Impact factor: 2.480

Review 6.  Interplay between DNA repair and inflammation, and the link to cancer.

Authors:  Dawit Kidane; Wook Jin Chae; Jennifer Czochor; Kristin A Eckert; Peter M Glazer; Alfred L M Bothwell; Joann B Sweasy
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-01-13       Impact factor: 8.250

7.  Effect of ERCC8 tagSNPs and their association with H. pylori infection, smoking, and alcohol consumption on gastric cancer and atrophic gastritis risk.

Authors:  Jing-Jing Jing; Li-Ping Sun; Qian Xu; Yuan Yuan
Journal:  Tumour Biol       Date:  2015-07-01

8.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Authors:  Siddavaram Nagini
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

Review 9.  Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines.

Authors:  Chandrani Sarkar; Debanjan Chakroborty; Sujit Basu
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-11       Impact factor: 4.147

10.  Outcome of FOLFOX and Modified DCF Chemotherapy Regimen in Patients with Advanced Gastric Adenocarcinoma.

Authors:  Mehdi Pourghasemian; Amin Danandeh Mehr; Mohammad Molaei; Afshin Habibzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.